Overview Multiple Ascending Dose Study of SPC5001 in Treatment of Healthy Subjects and Subjects With FH Status: Terminated Trial end date: 2011-11-01 Target enrollment: Participant gender: Summary The purpose is to study Safety and Tolerability. Phase: Phase 1 Details Lead Sponsor: Santaris Pharma A/S